{"id":10423,"date":"2026-11-17T16:48:26","date_gmt":"2026-11-17T16:48:26","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/essential-package-of-diagnostic-tests-for-bacterial-and-fungal-infections-and-antimicrobial-resistance\/"},"modified":"2026-11-17T16:48:26","modified_gmt":"2026-11-17T16:48:26","slug":"essential-package-of-diagnostic-tests-for-bacterial-and-fungal-infections-and-antimicrobial-resistance","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/essential-package-of-diagnostic-tests-for-bacterial-and-fungal-infections-and-antimicrobial-resistance\/","title":{"rendered":"Essential package of diagnostic tests for bacterial and fungal infections and antimicrobial resistance"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/0d9632e6-e04c-42ff-b751-fd85f210b1cc\/content\" alt=\"Essential package of diagnostic tests for bacterial and fungal infections and antimicrobial resistance\"><br \/>\n     <\/figure>\n<div class=\"button button-blue-background\"><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b4bf18cf-7647-4832-9024-4e6b224930e6\/content\" onclick=\"sendGaEvent('Download','https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b4bf18cf-7647-4832-9024-4e6b224930e6\/content')\">Download <span>(1.4 MB)<\/span><\/a><\/div><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<p>Access to reliable diagnostic testing for bacterial and fungal infections and antimicrobial susceptibility testing is essential to guide appropriate antimicrobial use, strengthen antimicrobial resistance surveillance and improve patient outcomes. Major gaps persist, especially in low- and middle-income countries. Building on the World Health Organization (WHO) model list of essential in vitro diagnostics, the WHO essential package of diagnostic tests for bacterial and fungal infections and antimicrobial resistance (EPD\u2013AMR) is a prioritized catalogue of rapid, microscopy, culture-based, serological and molecular tests mapped to the tiers of the health system, from primary care to tertiary hospitals.\n<\/p>\n<p>By specifying test purpose, specimen type and methodology at each health system level, and outlining key considerations for national implementation, the EPD\u2013AMR aims to guide policymakers, regulators, health-care providers and implementing partners in prioritizing and rolling out essential diagnostic services. Developed under the WHO Antimicrobial Resistance Diagnostic Initiative, the package supports equitable access to timely, quality-assured and accurate diagnosis, treatment and surveillance of bacterial and fungal infections and antimicrobial resistance<\/p>\n<div id=\"dynamic-content__accordion\" class=\"dynamic-content__accordion\">\n<p><a target=\"_blank\" href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240126343\">Toolkit of standard operating procedures for bacteriology, mycology and antimicrobial susceptibility testing<\/a><\/p>\n<p>\u00a0<\/p>\n<\/p><\/div><\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\n                             <a target=\"_blank\" href=\"https:\/\/www.who.int\/teams\/surveillance-prevention-control-AMR\/antimicrobial-surveillance-and-laboratory-strengthening\">Antimicrobial Resistance (AMR)<\/a>                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Editors<\/div>\n<div class=\"value\">World Health Organization<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">52<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">WHO Reference Number: <\/strong><span>B09666<\/span><\/div><\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Copyright<\/div>\n<p>                <a target=\"_blank\" class=\"creativecommons-icons-wrappers\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo\/deed.en\" rel=\"license\" title=\"Click here to see the details of CC BY-NC-SA 3.0 IGO\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/cc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/by.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/nc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/sa.svg\"><br \/>\n                <\/a>\n        <\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/B09666?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Download (1.4 MB) Overview Access to reliable diagnostic testing for bacterial and fungal infections and antimicrobial susceptibility testing is essential to guide appropriate antimicrobial use, strengthen antimicrobial resistance surveillance and improve patient outcomes. Major gaps persist, especially in low- and middle-income countries. Building on the World Health Organization (WHO) model list of essential in vitro diagnostics, the WHO essential package&hellip;<\/p>","protected":false},"author":99035,"featured_media":10424,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[1917,2370,2664,500,2854,1828,489,1918,2136],"ground_category":[315,316],"class_list":["post-10423","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-antimicrobial","tag-bacterial","tag-diagnostic","tag-essential","tag-fungal","tag-infections","tag-package","tag-resistance","tag-tests","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/0d9632e6-e04c-42ff-b751-fd85f210b1cc\/content","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=10423"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10423\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/10424"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=10423"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=10423"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=10423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}